Antiplatelet agents for chronic kidney disease
Cochrane database of systematic reviews, February 2013
Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Pellegrini F, Jardine MJ, Webster AC, Zoungas S, Strippoli GF, Palmer, Suetonia C, Di Micco, Lucia, Razavian, Mona, Craig, Jonathan C, Perkovic, Vlado, Pellegrini, Fabio, Jardine, Meg J, Webster, Angela C, Zoungas, Sophia, Strippoli, Giovanni FM
Antiplatelet agents are widely used to prevent cardiovascular events. The risks and benefits of antiplatelet treatment may be different in people with chronic kidney disease (CKD) for whom occlusive atherosclerotic events are less prevalent, and bleeding hazards might be increased.
|Members of the public||10||100%|